# Anzupgo

NDC: 50222-280
Generic name: delgocitinib
Labeler / Manufacturer: LEO Pharma, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20250724

FDA application: NDA219155

## Active ingredients

- DELGOCITINIB: 20 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50222-280"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50222-280
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a59bf36e-6f04-4b47-b385-8040c95f040c